cancer outcomes
Recently Published Documents





Gieira S. Jones ◽  
Katherine A. Hoadley ◽  
Halei Benefield ◽  
Linnea T. Olsson ◽  
Alina M. Hamilton ◽  

2022 ◽  
Vol 8 ◽  
Fang-Yu Yen ◽  
Wen-Kuei Chang ◽  
Shih-Pin Lin ◽  
Tzu-Ping Lin ◽  
Kuang-Yi Chang

Whether epidural anesthesia and analgesia (EA) is beneficial for postoperative cancer outcomes remains controversial and we conducted this historical cohort study to evaluate the association between EA and long-term outcomes following surgery for renal cell carcinoma (RCC). We collected patients receiving RCC surgery from 2011 to 2017 and followed up them until February 2020. Patient attributes, surgical factors and pathological features were gathered through electronic medical chart review. The association between EA and recurrence-free and overall survival after surgery was evaluated using Cox regression models with inverse probability of treatment weighting (IPTW) to balance the observed covariates. The median follow-up time for the 725 included patients was 50 months (interquartile range: 25.3–66.5) and 145 of them (20%) received perioperative EA. We demonstrated EA use was associated with better recurrence-free survival [IPTW adjusted hazard ratio (HR): 0.64, 95% confidence interval (CI): 0.49–0.83, p < 0.001] and overall survival [IPTW adjusted HR: 0.66, 95% CI: 0.49–0.89, p = 0.006] in patients receiving surgical resection for RCC. More prospective studies are needed to verify this connection between EA and superior cancer outcomes after RCC surgery.

Cancers ◽  
2022 ◽  
Vol 14 (2) ◽  
pp. 398
Daniel Redondo-Sánchez ◽  
Dafina Petrova ◽  
Miguel Rodríguez-Barranco ◽  
Pablo Fernández-Navarro ◽  
José Juan Jiménez-Moleón ◽  

In the past decade, evidence has accumulated about socio-economic inequalities in very diverse lung cancer outcomes. To better understand the global effects of socio-economic factors in lung cancer, we conducted an overview of systematic reviews. Four databases were searched for systematic reviews reporting on the relationship between measures of socio-economic status (SES) (individual or area-based) and diverse lung cancer outcomes, including epidemiological indicators and diagnosis- and treatment-related variables. AMSTAR-2 was used to assess the quality of the selected systematic reviews. Eight systematic reviews based on 220 original studies and 8 different indicators were identified. Compared to people with a high SES, people with a lower SES appear to be more likely to develop and die from lung cancer. People with lower SES also have lower cancer survival, most likely due to the lower likelihood of receiving both traditional and next-generation treatments, higher rates of comorbidities, and the higher likelihood of being admitted as emergency. People with a lower SES are generally not diagnosed at later stages, but this may change after broader implementation of lung cancer screening, as early evidence suggests that there may be socio-economic inequalities in its use.

2022 ◽  
pp. cebp.0583.2021
Brittany N Chao ◽  
Danielle M Carrick ◽  
Kelly K Filipski ◽  
Stefanie A Nelson

BMC Urology ◽  
2022 ◽  
Vol 22 (1) ◽  
Xiao-Fang Xia ◽  
Yi-Qiu Wang ◽  
Shi-Yi Shao ◽  
Xin-Yu Zhao ◽  
Shi-Geng Zhang ◽  

Abstract Objectives To describe the influence of the socioeconomic development on worldwide age-standardized incidence and mortality rates, as well as mortality-to-incidence ratio (MIR) and 5-year net survival of urologic cancer patients in recent years. Methods The Human Development Index (HDI) values were obtained from the United Nations Development Programme, data on age-standardized incidence/mortality rates of prostate, bladder and kidney cancer were retrieved from the GLOBOCAN database, 5-year net survival was provided by the CONCORD-3 program. We then evaluated the association between incidence/MIR/survival and HDI, with a focus on geographic variability as well as temporal patterns during the last 6 years. Results Urologic cancer incidence rates were positively correlated with HDIs, and MIRs were negatively correlated with HDIs. Prostate cancer survival also correlated positively with HDIs, solidly confirming the interrelation among cancer indicators and socioeconomic factors. Most countries experienced incidence decline over the most recent 6 years, and a substantial reduction in MIR was observed. Survival rates of prostate cancer have simultaneously improved. Conclusion Development has a prominent influence on urologic cancer outcomes. HDI values are significantly correlated with cancer incidence, MIR and survival rates. HDI values have risen along with increased incidence and improved outcomes of urologic caner in recent years.

Cathy J. Bradley ◽  
Amy Anderson-Mellies ◽  
Evelinn A. Borrayo ◽  
Jennifer Anne Doherty ◽  
Omar A. Escontrías ◽  

2022 ◽  
Vol 31 (1) ◽  
pp. 91-108
Vishnukamal Golla ◽  
Deborah R. Kaye

2021 ◽  
Vol Publish Ahead of Print ◽  
Michael Poulson ◽  
Alaina D. Geary ◽  
Chandler Annesi ◽  
Tracey Dechert ◽  
Kelly Kenzik ◽  

Sign in / Sign up

Export Citation Format

Share Document